High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison

Tools

Item Type:	Article
Title:	High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison
Creators Name:	Hiddemann, W., Aul, C., Maschmeyer, G., Schoenrock-Nabulsi, R., Ludwig, W.D., Bartholomaeus, A., Bettelheim, P., Becker, K., Balleisen, L., Lathan, B., Koeppler, H., Grueneisen, T., Donhuijsen-Ant, R., Reichle, A., Heinecke, A., Sauerland, C. and Buechner, T.
Source:	Leukemia & Lymphoma
ISSN:	1042-8194
Volume:	10 Suppl.
Page Range:	133-137
Date:	1 January 1993
PubMed:	View item in PubMed

Repository Staff Only: item control page